26,311.55
(-126.45)
(-0.47%)
01 Oct , 2026 | 04:14 PM
Open
26,408.95
Prev. Close
26,438
Market Cap.
₹20,73,967.71
Div Yield
0.54
PE
40.9
PB
40.9
26,020.45
26,517.4
Performance
One Week (%)
-2.62
One Month (%)
-2.75
One Year (%)
23.22
YTD (%)
20.1
Company Name | CMP | High | Low | Volume |
|---|---|---|---|---|
Abbott India Ltd | 26,840 | 27,330 | 26,435 | 6,879 |
Cipla Ltd | 1,344 | 1,359.4 | 1,333.4 | 9,21,789 |
Dr Reddys Laboratories Ltd | 1,206.2 | 1,233.9 | 1,194.9 | 26,07,818 |
Lupin Ltd | 2,031.2 | 2,044.1 | 2,004.2 | 8,25,892 |
Torrent Pharmaceuticals Ltd | 4,767.3 | 4,810.5 | 4,717.3 | 3,57,701 |
Ipca Laboratories Ltd | 1,943.2 | 1,966.8 | 1,880.8 | 3,23,967 |
Sun Pharmaceutical Industries Ltd | 1,801 | 1,828.7 | 1,792.6 | 23,14,700 |
Aurobindo Pharma Ltd | 1,676.8 | 1,700.7 | 1,654.2 | 10,74,057 |
Wockhardt Ltd | 2,083.9 | 2,124 | 2,035.6 | 7,84,540 |
Ajanta Pharma Ltd | 3,581 | 3,602.4 | 3,489.6 | 75,759 |
Gland Pharma Ltd | 2,874.4 | 2,929.8 | 2,841.1 | 3,27,673 |
Biocon Ltd | 370.7 | 374.25 | 363.6 | 25,25,268 |
Alkem Laboratories Ltd | 5,220 | 5,220 | 5,110 | 2,91,015 |
Glenmark Pharmaceuticals Ltd | 2,331 | 2,360 | 2,279.3 | 9,72,522 |
Zydus Lifesciences Ltd | 1,145.7 | 1,158 | 1,123.7 | 25,47,369 |
Divis Laboratories Ltd | 9,249 | 9,318 | 9,078 | 5,67,310 |
Mankind Pharma Ltd | 2,535 | 2,535 | 2,476.1 | 4,27,905 |
Laurus Labs Ltd | 1,984 | 2,006.9 | 1,952.1 | 14,59,687 |
Sai Life Sciences Ltd | 1,541.2 | 1,556.9 | 1,493.1 | 5,84,535 |
Piramal Pharma Ltd | 197.97 | 206.7 | 195.73 | 35,74,489 |
The Indian stock market is under pressure as geopolitical tensions, rising crude oil prices, higher US Treasury yields, rupee weakness and foreign investor selling trigger a broad-based sell-off in Nifty and Sensex.
28 Sep 2026|11:12 AM
Nifty Today: Indian markets faced heavy selling pressure as Nifty fell 370 points, crude oil surged above $105 and India VIX jumped 25%. US bond yields and geopolitical tensions added to market volatility.
24 Sep 2026|04:31 PM
The NSE IPO opens on September 17 with a price band of ₹1,700–₹1,785 per share. NSE CEO Ashish Chauhan said demand has been unexpectedly large, while the GMP has cooled to ₹145 from ₹218 on September 11.
16 Sep 2026|11:13 AM
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
